{
  "full_extraction": {
    "study_characteristics": {
      "study_id": "vanRijn_2021",
      "first_author": "van Rijn",
      "year": 2021,
      "title": "Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial",
      "journal": "The New England Journal of Medicine",
      "doi": "10.1056/NEJMoa2031532",
      "study_design": "RCT",
      "is_multicenter": true,
      "countries": [
        "Netherlands",
        "Belgium",
        "United Kingdom"
      ],
      "registry_id": "NCT02584283",
      "intervention_type": "DHOPE",
      "comparator": "SCS",
      "n_intervention": 78,
      "n_control": 78,
      "n_total": 156,
      "donor_type": "DCD"
    },
    "perfusion_settings": {
      "device_name": "Liver Assist (Organ Assist)",
      "cannulation": "Dual (PV+HA)",
      "perfusate_type": "Belzer MPS UW machine-perfusion solution supplemented with 3 mmol of glutathione per liter",
      "temperature_setting": "Hypothermic",
      "temperature_celsius": 10.0,
      "study_id": "vanRijn_2021"
    },
    "time_metrics": {
      "perfusion_initiation": "Recipient hospital (end-ischemic)",
      "perfusion_time_hours": 2.2,
      "study_id": "vanRijn_2021"
    },
    "outcome_data": {
      "follow_up_months": 6.0,
      "ead": {
        "reported": true,
        "definition": "any one of the following clinical indicators: a bilirubin level of at least 171 μmol per liter (10 mg per deciliter) on postoperative day 7; an international normalized ratio of at least 1.6 on postoperative day 7; or alanine aminotransferase and aspartate aminotransferase levels of more than 2000 U per liter within the first 7 postoperative days.",
        "intervention_events": 20,
        "intervention_total": 78,
        "control_events": 31,
        "control_total": 78,
        "rr": 0.61,
        "ci_lower": 0.39,
        "ci_upper": 0.96,
        "p_value": null,
        "source_quote": "Early allograft dysfunction occurred in 26% of the machine-perfused livers, as compared with 40% of control livers (risk ratio, 0.61; 95% CI, 0.39 to 0.96).",
        "source_location": "Results p.1 / Table 2"
      },
      "nas": {
        "reported": true,
        "definition": "any irregularity or narrowing of the lumen of the intrahepatic or extrahepatic donor bile ducts, excluding the biliary anastomosis, diagnosed with the use of cholangiography (preferably, magnetic resonance cholangiography), in combination with clinical symptoms (e.g., jaundice or cholangitis) or an elevation of cholestatic laboratory variables, in the presence of a patent hepatic artery.",
        "follow_up_for_nas_months": 6.0,
        "intervention_events": 5,
        "intervention_total": 78,
        "control_events": 14,
        "control_total": 78,
        "rr": 0.36,
        "ci_lower": 0.14,
        "ci_upper": 0.94,
        "p_value": 0.03,
        "source_quote": "Nonanastomotic biliary strictures occurred in 6% of the patients in the machine-perfusion group and in 18% of those in the control group (risk ratio, 0.36; 95% confidence interval [CI], 0.14 to 0.94; P = 0.03).",
        "source_location": "Results p.1 / Table 2"
      },
      "pnf": {
        "reported": true,
        "intervention_events": 0,
        "intervention_total": 78,
        "control_events": 1,
        "control_total": 78,
        "source_quote": "There were no cases of primary non-function in the machine-perfusion group, but one case was observed in the control group.",
        "source_location": "Results p.7 / Table 2"
      },
      "graft_survival_1yr": {
        "reported": true,
        "intervention_percent": null,
        "control_percent": null,
        "hr": 0.65,
        "ci_lower": 0.18,
        "ci_upper": 2.29,
        "p_value": null,
        "source_quote": "Hazard ratio for graft survival 0.65 (95% CI, 0.18 – 2.29)",
        "source_location": "Supplementary Appendix Fig S3"
      },
      "patient_survival_1yr": {
        "reported": true,
        "intervention_percent": null,
        "control_percent": null,
        "hr": 2.45,
        "source_quote": "Hazard ratio for patient survival 2.45 (95% CI, 0.77 – 7.85)",
        "source_location": "Supplementary Appendix Fig S3"
      },
      "study_id": "vanRijn_2021"
    },
    "extraction_notes": {
      "data_quality_concerns": null,
      "unclear_items_for_review": [
        "Survival HRs are reported in the Supplementary Appendix but not the main text results table."
      ],
      "general_notes": "This was a multicenter RCT specifically for DCD livers using dual hypothermic oxygenated perfusion (DHOPE). 160 patients were randomized, but 4 were excluded before trial procedures (156 analyzed in ITT)."
    }
  },
  "rob_information": {
    "study_id": "vanRijn_2021",
    "d1_randomization": {
      "judgment": "Low",
      "rationale": "The study used a computer-generated, centralized balanced-block randomization sequence with stratification. Allocation concealment was maintained until after the liver was accepted for transplantation.",
      "support_quotes": [
        "Centralized balanced-block randomization (in blocks of six) was computer-generated, with stratification according to trial center and primary sclerosing cholangitis as an indication for transplantation (yes or no).",
        "Randomization took place immediately after a donor liver had been deemed to be suitable and had been accepted by the transplantation surgeon for a recipient."
      ]
    },
    "d2_deviations": {
      "judgment": "Low",
      "rationale": "While surgical personnel could not be blinded to the use of a machine perfusion device, patients and procurement teams were blinded. The primary outcome assessment was performed by blinded radiologists, mitigating the risk of bias from lack of personnel blinding.",
      "support_quotes": [
        "Patients and the organ-procurement teams were unaware of the trial-group assignments.",
        "All end-point analyses were prespecified in the protocol and statistical analysis plan, which was finalized before the database was locked."
      ]
    },
    "d3_missing_data": {
      "judgment": "Low",
      "rationale": "Attrition was very low. Only 4 patients out of 160 randomized did not receive the intervention, and these exclusions occurred before the trial procedures began for reasons unrelated to the assigned group.",
      "support_quotes": [
        "A total of 160 patients were enrolled, of whom 78 received a machine-perfused liver and 78 received a liver after static cold storage only (4 patients did not receive a liver in this trial).",
        "Missing data were assumed to be missing at random, and multiple imputation was performed when more than 10% of all the patients had missing data for a specific variable."
      ]
    },
    "d4_measurement": {
      "judgment": "Low",
      "rationale": "The primary outcome (nonanastomotic biliary strictures) was assessed using objective imaging (cholangiography) and reviewed by independent radiologists who were blinded to the treatment group.",
      "support_quotes": [
        "All the cholangiographies, both in patients who were symptomatic and in those who were asymptomatic, were reviewed by two independent radiologists who were unaware of the preservation method and clinical symptoms."
      ]
    },
    "d5_selection": {
      "judgment": "Low",
      "rationale": "The trial was pre-registered on ClinicalTrials.gov, and the protocol was published prior to the completion of the study. Reported results align with the pre-specified outcomes.",
      "support_quotes": [
        "The trial protocol, which is available with the full text of this article at NEJM.org, has been published previously.",
        "DHOPE-DCD ClinicalTrials.gov number, NCT02584283."
      ]
    },
    "overall_judgment": "Low",
    "overall_rationale": "The trial was well-conducted with robust randomization, clear allocation concealment, and blinded outcome adjudication for the primary endpoint. Missing data were minimal and handled appropriately."
  },
  "study_type": "RCT",
  "study_id": "vanRijn_2021"
}